Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Abstract Aims Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large‐scale patient treatment. We aim to investigate the clinical safety and efficacy profile of the allogeneic adipose tissue derived mesenchymal stromal cell product (CSCC_ASC) as an...

Full description

Bibliographic Details
Published in:	ESC Heart Failure
Main Authors:	Abbas Ali Qayyum, Sabina Frljak, Morten Juhl, Gregor Poglajen, Gregor Zemljičl, Andraz Cerar, Thomas Litman, Annette Ekblond, Mandana Haack‐Sørensen, Lisbeth Drozd Højgaard, Jens Kastrup, Bojan Vrtovec
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Subjects:	Adipose tissue derived mesenchymal stromal cells Allogeneic therapy Clinical trial Heart failure Stem cells
Online Access:	https://doi.org/10.1002/ehf2.14925

Similar Items

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
by: Gregor Poglajen, et al.
Published: (2019-07-01)

Investigating the paracrine and juxtacrine abilities of adipose-derived stromal cells in angiogenesis triple cell co-cultures
by: Rebekka Harary Søndergaard, et al.
Published: (2024-06-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
by: Sabina Frljak, et al.
Published: (2022-03-01)

Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course
by: Gregor Zemljic, et al.
Published: (2025-09-01)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
by: Cecilie Hoeeg, et al.
Published: (2020-12-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01)

GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
by: Mandana Haack-Sørensen, et al.
Published: (2022-01-01)

Stem Cell Therapy in Patients with Chronic Nonischemic Heart Failure
by: Gregor Poglajen, et al.
Published: (2018-01-01)

Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
by: Marko Banovic, et al.
Published: (2022-12-01)

Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation
by: Abbas Ali Qayyum, MD, MSc, PhD, et al.
Published: (2025-05-01)

TNF-α Predicts Endothelial Function and Number of CD34<sup>+</sup> Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure
by: Sabina Ugovšek, et al.
Published: (2022-08-01)

Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
by: Andraz Cerar, et al.
Published: (2020-06-01)

Response to the letter to the editor: unravel the genetic background of noncompaction before relating it with myocardial hypoperfusion
by: Andraz Cerar, et al.
Published: (2020-08-01)

THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014-07-01)

FLUDARABINE-MELPHALAN-CAMPATH FOLLOWED BY UNMANIPULATED PERIPHERAL-BLOOD HAEMATOPOIETIC STEM CELLS CAN STILL CURE LYMPHOMA.
by: Daniele Avenoso, et al.
Published: (2023-06-01)

The effects of allogenic stem cells in a murine model of hind limb diabetic ischemic tissue
by: Jesús Álvarez García, et al.
Published: (2017-08-01)

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-10-01)

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-12-01)

Quimerismo molecular en el trasplante alogénico de células hematopoyéticas: Resultados preliminares Molecular chimerism in the allogeneic transplantation of hematopoietic cells: Preliminary results
Published: (2005-12-01)

THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014-07-01)

Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction
by: Bjarke Follin, et al.
Published: (2018-01-01)

Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center
by: Mathias Castonguay, et al.
Published: (2025-05-01)

Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products
by: Chen-Yuan Kao, et al.
Published: (2023-05-01)

Circulating mesenchymal stem cells and their clinical implications
by: Liangliang Xu, et al.
Published: (2014-01-01)

Coexisting Pulmonary Tuberculosis and Mucormycosis in a Patient with Aplastic Anemia Post Allogenic Stem Cell Transplantion
by: Sanjeev Kumar Sharma, et al.
Published: (2011-09-01)

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020
by: Helena Simeunovic, et al.
Published: (2023-02-01)

Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity
by: Hajar Y. AlQahtani, et al.
Published: (2024-07-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
by: Anne-Béatrice Notarantonio, et al.
Published: (2024-05-01)

Allogeneic CAR Cell Therapy—More Than a Pipe Dream
by: Kenneth J. Caldwell, et al.
Published: (2021-01-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses
by: Grammatiki Fotaki, et al.
Published: (2018-03-01)

LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
by: Shuxian Zhu, et al.
Published: (2025-01-01)

Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review
by: Tihomir Georgiev-Hristov, et al.
Published: (2022-10-01)

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis
by: Alexander Biederstädt, et al.
Published: (2025-07-01)

Allogeneic fibroblast sheets prevent pulmonary air leaks caused by rat pleural defects without adhesion to the thoracic wall
by: Hiroaki Shidei, et al.
Published: (2025-03-01)

Fluvastatin Promotes Treg Cell Production in Allogeneic Immune Reaction and Suppresses Inflammatory Response
by: Xianxian Chen, et al.
Published: (2025-02-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Allogeneic Stem Cell Transplantation Experience in Chronic Lymphocytic Leukemia
by: Erden Atilla, et al.
Published: (2018-04-01)

Recent advancements in hematopoietic stem cell transplantation in Taiwan
by: Chi-Cheng Li, et al.
Published: (2024-01-01)